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Abstract
Background: The immune stimulating bacterium Propionibacterium acnes is a frequent colonizer of benign and 
malignant prostate tissue. To understand the pathogenesis of the earliest phase of this infection, we examined the P. 
acnes triggered immune response in cultivated prostate epithelial cells.
Results: Prostate epithelial cells are triggered to secrete IL-6, IL-8 and GM-CSF when infected with P. acnes. The 
secretion of cytokines is accompanied by NFκB related upregulation of the secreted cytokines as well as several 
components of the TLR2-NFκB signaling pathway.
Conclusions: P. acnes has potential to trigger a strong immune reaction in the prostate glandular epithelium. Upon 
infection of prostate via the retrograde urethral route, the induced inflammatory reaction might facilitate bacterial 
colonization deeper in the prostate tissue where persistent inflammation may impact the development of prostate 
diseases as hyperplasia and/or malignancy.
Background
Asymptomatic histological inflammation is a common
feature when prostate tissue is subjected to morphologi-
cal examination. Varying degree of inflammation is pres-
ent at both benign (prostatic hyperplasia) and malignant
(neoplasia) conditions. A growing amount of research
supports the idea that chronic prostatic inflammation
contributes to gradual transition of normal epithelial cells
to malignant cells [1]. For example, many of the gene-
variants linked to familiar prostate cancer code for proin-
flammatory cytokines and chemokines [2]. A plethora of
microorganisms have been evaluated for their possible
involvement in the etiology of prostate inflammation.
Many studies purported E. coli and sexually transmitted
agents as likely candidates capable of inducing chronic
prostatic inflammation [3-5]. A Gram-positive bacte-
rium;  Propionibacterium acnes (P. acnes) has been
reported to be frequently present in various prostatic dis-
eases (as reviewed in [6]) and its presence has been corre-
lated to inflammation in prostate cancer specimens [7-9].
P. acnes, a well studied pathogenetic factor in cutaneous
disorders like acne vulgaris, has been demonstrated to
stimulate monocytes and endothelial cells to secrete pro-
inflammatory cytokines via activation of Toll-like recep-
tor (TLR) 2 [10,11]. In this study we present an in vitro
model to study the inflammatory response of prostate
derived epithelial cells to P. acnes infection. We report
that  P. acnes induces upregulation of numerous pro-
inflammatory substances at the mRNA level accompa-
nied by secretion of respective soluble substances such as
interleukins 6, 8 and GM-CSF. Components of the TLR2-
NFκB signaling pathway were upregulated, suggesting an
involvement of this particular pathway for the response.
Blocking of the TLR2 with monoclonal antibodies partly
reduced the effects.
Results
Pilot studies to define experimental conditions for P. acnes 
infection of epithelial cells
Secretion of cytokines is one of the end results of innate
immune response at a cellular level. We therefore
assessed the secretion of three key cytokines, IL-6, IL-8
and GM-CSF (also called CSF-2) from the prostate-
derived epithelial cell-line RWPE-1 in response to infec-
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tion with P. acnes. To set experimental conditions as mul-
tiplicity of infection (MOI) and useful infection time, we
defined the desired criteria as maximal cytokine secre-
tion after 48 h and no visual cellular detachment or cell-
death. A MOI of 16-40:1 fulfilled these criteria (data not
shown). We therefore decided to use a MOI of 16:1 for
the following experiments.
Prostate epithelial cells secrete IL-6, IL-8, and GM-CSF in 
response to Propionibacterium acnes infection
Secretion of cytokines IL-6, IL-8 and GM-CSF by RWPE-
1 was measured 24 h and 48 h after infection with P.
acnes. 24 h after infection, the levels of secreted IL-6, IL-8
and GM-CSF were: 441.7 ± 67.6, 3071.1 ± 133.7, and 48.6
± 3.1 (pg/ml), respectively. The corresponding values
from the uninfected control cells were: 17.0 ± 8.0 (pg/ml),
not detectable, not detectable (Figure 1). 48 h after infec-
tion, the concentrations increased to: 567.7 ± 70.7, 5121.5
± 218.0, and 118.6 ± 10.6 (pg/ml). Uninfected: 19.9 ± 5.8,
320.6 ± 71.4, and 2.1 ± 0.5 (pg/ml). The diagram shows
means for triplicates with the error bars representing the
standard deviation [12] (Figure 1).
P. acnes induced secretion of IL-8 is partially blocked by α-
TLR-2 antibodies
To determine whether the secretion of IL-6, IL-8, and
GM-CSF was TLR2-mediated, TLR2 on RWPE-1 cells
were blocked with monoclonal anti-TLR2 antibodies at a
concentration of 100 ng/ml prior to infection. This par-
ticular mab clone has previously been demonstrated to
block TLR2 activation in human cells [13]. Secretion of
IL-8 was significantly (p = 0.05) reduced when measured
24 h after infection (Figure 2). No such blocking effect
was recognizable 48 h after infection. Levels of IL-6 and
GM-CSF were not significantly affected (Figure 2). Figure
2 shows means for triplicates with the error bars repre-
senting the standard deviation.
P. acnes infection induces up-regulation of several 
cytokines and components of the TLR-2 signaling pathway
The potent P. acnes stimulated effect on secretion of IL-6,
IL-8 and GM-CSF prompted us to investigate an array of
genes involved in inflammatory signaling pathways. As
our main focus is the early responses, we wanted to col-
lect mRNA as early as possible, yet late enough to allow
observation of significant regulatory events. We used the
cDNA prepared from cells infected for 24 h for compari-
son with cDNA from uninfected cells. Of the 84 genes
analyzed, 20 were more than two-fold upregulated (p =
0.05): CCL2, CSF2 (GM-CSF), CSF3, CXCL10, IFNB1,
IL1A, IL6, IL8, IRAK2, IRF1, JUN, LTA, NFKB2, NFK-
BIA, REL, RELA, RIPK2, TLR2, TNF, and TICAM1
(Table 1). Only four genes were downregulated (p = 0.05):
FOS, HMGB1, TLR4 and UBE2V1 (Table 2).
Discussion
Prostate specimens commonly display signs of chronic
histological inflammation, along with occasional acute
inflammation. Numerous studies have explored a possi-
ble link between prostate inflammation and cancer devel-
opment and recent reviews of epidemiologic, genetic, and
molecular studies have collectively suggested that the two
cellular processes may indeed interact [2,14-16]. Expo-
sure to environmental factors such as infectious agents
Figure 1 P. acnes-induced secretion of IL-6 (a), IL-8 (b) and GM-
CSF (c) by RWPE-1 cells at 24 h and 48 h after infection. Semicon-
fluent RWPE-1 monocell-layers were infected with P. acnes at a MOI of 
16:1. Cytokines released into supernatants were quantified by ELISA. 
The diagram shows means for triplicates with the error bars represent-
ing the standard deviation.Drott et al. BMC Microbiology 2010, 10:126
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can lead to injury of the prostate and to the development
of chronic inflammation [17]. The intrinsic interplay
between microbes and urogenital cells is a key feature in
the understanding of the microbial involvement in pros-
tate disease. Both Chlamydia and Mycoplasma have been
demonstrated to induce IL-6 and IL-8 production in
immortalized normal prostate epithelial cells (PNT2)
[18,19]. Given the emergence of P. acnes as an infecting
agent in prostate tissue [7-9] we investigated the effect of
the bacterium on prostate epithelial cells of non-malig-
nant origin (RWPE-1). In vitro, P. acnes induced consid-
erable secretion of IL-6 and IL-8 and, to a lesser extent,
GM-CSF. Secretion of IL8 was shown to be mediated via
TLR2, as the receptor blockage with anti-TLR2 monoclo-
nal antibodies reduced its secretion. In contrast, we did
not observe any significant reduction in secretion of IL-6
and GM-CSF by blockage of TLR2. Earlier reports pres-
ent evidence that P. acnes is able to stimulate monocytes
and endothelial cells to secrete pro-inflammatory cytok-
ines via activation of TLR2 [10,11]. Our results partly
confirm this. Even toll-like receptors 4 and 9 have been
implicated in P. acnes mediated immune modulatory
effects [20]. Both human and rat prostate epithelial cell
lines are known to express TLR2, TLR4, and TLR9
[21,22] and since blockage of TLR2 in our experiment has
not totally inhibited cytokine secretion, the involvement
of other TLR may also be hypothesized. However, possi-
ble TLR4 involvement is compromised by the observed
downregulation of the gene expression. Another mecha-
nism may involve auto inducing capability of the released
cytokines that generates a self-perpetuating inflamma-
tory process.
The increased secretion of such cytokines was accom-
panied by concordant mRNA up-regulation. Moreover,
the broader analysis of inflammation associated genes
revealed that chemokine ligands and pro-inflammatory
substances CCL2, CXCL10, TNF-α, TNF-β (lymphoto-
xin-α), CSF3, IL1-α, and IFN-β were also significantly
upregulated. Further studies are required to determine if
upregulation of aforementioned genes is accompanied by
enhanced cytokine production by prostate epithelial cells.
The upregulation of the transcriptional regulators JUN,
REL, RIPK2, NFKB2, NFKBIA, IRF1, IRAK2 and the
TLR/IL1-receptor co-factor TICAM1 is coherent with
earlier studies of TLR2 signaling cascade leading to Fib
activation [23,24].
Secretion of IL-6, IL-8 and GM-CSF are central for
recruitment and differentiation of macrophages and neu-
trophils in inflamed tissue [25-27]. A prolonged time of
increased cytokine levels might have adverse effects on
the tissue. P. acnes induced elevation of IL-8 expression in
hair-follicle endothelial cells is associated with epidermal
hyperplasia and follicular hyperkeratosis in acne vulgaris
and psoriasis [28,29]. There is also a correlation between
the more pronounced IL-8 expression and dermal angio-
genesis [29]. Interestingly, both IL-6 and IL-8 have been
suggested as contributors to prostate cancer develop-
ment. The expression of IL-6 and its receptor has been
demonstrated in clinical specimens of both prostate can-
cer and benign prostate hyperplasia [30], and levels of IL-
6 increase in organ-confined tumors [31]. In vitro experi-
ments have shown that IL-6 may play a role in prostate
cancer cell growth and differentiation and that it stimu-
lates cell growth of malignant cells [32]. Following pro-
Figure 2 α-TLR2 inhibition of IL6, IL-8 and GM-CSF secretion by P. 
acnes-infected RWPE-1. α-TLR2 mouse monoclonal antibodies (100 
ng/ml) were added one hour prior to P. acnes infection of semiconflu-
ent RWPE-1 monocell-layers. Supernatants were collected at 24 h and 
48 h after infection. The amount of cytokines released into the medium 
was quantified by ELISA. The diagram shows means for triplicates with 
the error bars representing the standard deviation.Drott et al. BMC Microbiology 2010, 10:126
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longed treatment with IL-6, prostate cancer cells can alter
the responsiveness to the cytokine and acquire the ability
to proliferate at a higher rate and become more tumori-
genic [33,34]. IL-8 has been shown to increase the tran-
scriptional activity of the androgen receptor in prostate
cancer cell lines, suggesting a potential role of this
chemokine in modulating the transition of prostate can-
cer to an androgen-independent state [35]. Other studies
report that IL-8 contribution to prostate cell proliferation
is independent of the androgen receptor [36]. Our data
indicate that the prostate epithelium significantly con-
tributes to locally increased levels of both IL-6 and IL-8
when infected with P. acnes, thus potentially promoting
adverse effects as increased proliferation and angiogenic
activities by autocrine and/or endocrine mechanisms.
The pathogenesis of P. acnes in locations other than the
hair-follicle is still poorly understood. We currently
address questions about its involvement in prostate dis-
ease such as prevalence, genetic variability and impact on
histological inflammation and neoplasia (Elgh et al., man-
uscripts in preparation).
Conclusions
In conclusion, we demonstrate that prostate epithelial
cells secrete inflammatory cytokines in response to P.
acnes, partly through a TLR2-mediated mechanism. We
propose that this strong immune-stimulating effect facili-
tates the bacterial colonization deeper into the prostate
tissue where P. acnes can form long-lasting biofilm-like
aggregates [7]. A possible mechanism may involve intrac-
ellular transport in recruited macrophages, as P. acnes
has been demonstrated to withstand degradation by
phagocytosing mononuclear cells [37].
Methods
Prostate cell lines
RWPE-1, human prostate epithelial cell line (ATCC©
CRL-11609) was maintained in complete KSF-medium
supplemented with 5 ng/l EGF, 0.05 mg/l BPE and 100 U/
ml PEST (GIBCO BRL/Life technologies, Inc., Gaithers-
burg, MD, USA).
Cells were split 1:5, 1-2 times per week using 0,05% (w/
v) trypsin/EDTA (GIBCO BRL/Life technologies, Inc.,
Gaithersburg, MD, USA). Cells were maintained in a
humidified incubator at 37C containing 5% CO2.
Propionibacterium acnes
P. acnes, serotype 1a, isolated from craniopharyngeom
fluid was grown in Brain-Heart Infusion Broth + 5%
horse serum at 37C under microaerobic conditions. The
Table 1: List of genes that are upregulated upon P. acnes infection.
Gene name Description Fold upregulation
CCL2 Chemokine (C-C motif) ligand 2 41
CSF2 Colony stimulating factor 2 (granulocyte-macrophage) 139
CSF3 Colony stimulating factor 3 (granulocyte) 39
CXCL10 Chemokine (C-X-C motif) ligand 10 107
IFNB1 Interferon, beta 1, fibroblast 12
IL1A Interleukin 1, alpha 12
IL6 Interleukin 6 (interferon, beta 2) 34
IL8 Interleukin 8 336
IRAK2 Interleukin-1 receptor-associated kinase 2 11
IRF1 Interferon regulatory factor 1 12
JUN Jun oncogene 10
LTA Lymphotoxin alpha (TNF superfamily, member 1) 5
NFKB2 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) 8
NFKBIA Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 6
REL V-rel reticuloendotheliosis viral oncogene homolog 4
RELA V-rel reticuloendotheliosis viral oncogene homolog A, 2
RIPK2 Receptor-interacting serine-threonine kinase 2 4
TLR2 Toll-like receptor 2 3
TNF Tumor necrosis factor (TNF superfamily, member 2) 53
TICAM1 Toll-like receptor adaptor molecule 1 3
Semiconfluent RWPE-1 monocell-layers were infected with P. acnes at a MOI of 16:1. After 24 h infection, the cells were harvested, mRNA was 
collected and cDNA was prepared. The cDNA corresponding to 84 inflammation-associated genes was quantified with qRT-PCR and 
compared with cDNA prepared from non-infected cells. Inclusion criteria: > 2-fold up-regulation, (p = 0.05).Drott et al. BMC Microbiology 2010, 10:126
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bacteria were grown to a density of 109 per ml, pelleted
and resuspended into sterile PBS.
Cytokine ELISA
RWPE-1 cells were seeded into 24-well plates at a density
of 1 × 105cells per well in one ml normal growth medium.
After 48 h, cells were washed in PBS and the medium was
changed to DMEM without FCS and PEST. Cells were
infected with P. acnes at a MOI of 16:1 and immediate
close contact between bacteria and cells was achieved by
centrifugation of the flask for 10 min at 700 g. Non-
infected cells were used as controls.
For the TLR2 blocking experiments, RWPE-1 cells were
pre-treated with mouse anti-mouse/human TLR2 mAb
(clone T2.5 [13] cat.code: mab-mtrl2, InVivoGen, San
Diego, USA) at the concentration 100 ng/ml for 1 h. The
cells were then infected with P. acnes as described above.
Supernatants were harvested after 24 h and 48 h.
Supernatants were cleared from particles by centrifuga-
tion 10 min at 12000 g, stored at -20C and later assayed
for IL-6, IL-8 and GM-CSF by ELISA (R&D systems,
Minneapolis, Minnesota) according to manufacturer's
instruction.
RNA preparation and Reverse Transcription PCR
Cells were seeded at a density of 1 × 106 in a 25 cm2 cul-
ture flask in normal growth medium. After 48 h, cells
were washed in PBS and the medium were changed to
DMEM without FCS and PEST. Cells were infected with
P. acnes at a MOI of 16:1 and immediate close contact
between bacteria and cells were achieved by centrifuga-
tion of the flask for 10 min at 700 g. Total RNA was pre-
pared after 0 h and 24 h using RNeasy Mini kit (Qiagen,
Hilden, Germany) with the on-column DNase treatment
step according to manufacturer's instruction. Cells were
trypsinised using 0,05% (w/v) trypsin/EDTA, lysed in 350
μl RTL buffer and homogenized in a TissueLyser with
Stainless steel Beads, 5 mm (Qiagen, Hilden, Germany).
RNA concentration and purity were assessed in a Nan-
oDrop© ND-1000 spectrophotometer (Thermo scientific,
Wilmington, USA) at A260 and the ratios of A260:A230
and A260:280.
Complementary DNA (cDNA) was generated from one
μg total RNA using RT2 First strand kit (SABiosciences,
Frederick, MD, USA) according to the manufacturer's
instruction. Quality of the cDNA was verified by PCR
array housekeeping genes: beta-2-microglobulin, hypox-
anthine phosphoribosyltransferase 1, ribosomal protein
L13a, glyceraldehyde-3-phosphate dehydrogenase, beta-
actin using primers from (SABiosciences, Frederick, MD,
USA).
Real-time Quantitative PCR
Gene expression analysis measuring transcription of 84
inflammation associated genes was conducted using the
RT2 Profiler PCR Array, Human Toll-Like Receptor Sig-
naling Pathway PAHS-018A (SABiosciences, Frederick,
MD, USA) according to manufacturer's instruction. Real-
time PCR detection was performed with an IQ™5 instru-
ment (Bio-Rad, Hercules, CA, USA).
C o m p l e t e  l i s t  o f  g e n e s  a n a l yz ed  b y  t h e  a rr a y  ca n  be
found at: http://www.SABiosciences.com
Data Analysis
Relative gene expression was calculated with the ΔΔCt
method in the web-based software package for RT2 Pro-
filer PCR array systems (SABiosciences, Frederick, MD,
USA).
Statistical Methods
Due to the small sample size (n = 3), a permutation test
was used to test possible regulation [38]. A null hypothe-
sis corresponding to no regulation was tested for each
gene and each protein concentration and rejected for p =
0.05.
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Table 2: List of genes that are downregulated upon P. acnes infection.
Gene name Description Fold upregulation
FOS V-fos FBJ murine osteosarcoma viral oncogene homolog -3
HMGB1 High-mobility group box 1 -3
TLR4 Toll-like receptor 4 -4
UBE2V1 Ubiquitin-conjugating enzyme E2 variant 1 -3
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